Heart transplantation in insulin-treated diabetic mellitus patients with diabetes-related complications

Transplant International

Volumn 20, Issue 6, 2007, Pages 528-533

  Ikeda, Yoshifumi ^a,b   Tenderich, Gero ^a   Zittermann, Armin ^a   Minami, Kazutomo ^a   Koerfer, Reiner ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Diabetes mellitus; Diabetes related complications; Heart transplantation; Immunosuppressive therapy

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; INSULIN; STEROID;

ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADULT; AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 34247891800     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00478.x     Document Type: Article

References (23)

1. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB. Mortality among diabetics in a national sample. Am J Epidemiol 1988 128: 389.
2. Shindler DM, Kostis JB, Yusuf S, et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol 1996 77: 1017.
3. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001 161: 996.
4. Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol 2001 38: 421.
5. Griepp RB. A decade of human heart transplantation. Transplant Proc 1979 11: 285.
6. Lower RR, Szentpetery S, Quinn J, Thomas FT. Selection of patients for cardiac transplantation. Transplant Proc 1979 11: 293.
7. Badellino MM, Cavarocchi NC, Narins B, et al. Cardiac transplantation in diabetic patients. Transplant Proc 1990 22: 2384.
8. Livi U, Bortolotti U, Faggian G, Chiominto B, Mazzucco A, Gallucci V. Safety of cyclosporine monotherapy after heart transplantation. Transplant Proc 1990 22: 1441.
9. Livi U, Luciani GB, Boffa GM, et al. Clinical results of steroid-free induction immunosuppression after heart transplantation. Ann Thorac Surg 1993 55: 1160.
10. Tenderich G, Schulte-Eistrup S, Petzoldt R, Koerfer R. Cardiac transplantation in patients with insulin treated diabetes mellitus. Exp Clin Endocrinol Diabetes 2000 108: 249.
11. Russo MJ, Chen JM, Hong KN, et al. Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United States Network of Organ Sharing Database. Circulation 2006 114: 2280.
12. Rhenman MJ, Rhenman B, Icenogle T, Christensen R, Copeland J. Diabetes and heart transplantation. J Heart Transplant 1988 7: 356.
13. Munoz E, Lonquist JL, Radovancevic B, et al. Long-term results in diabetic patients undergoing heart transplantation. J Heart Lung Transplant 1992 11: 943.
14. Aleksic I, Czer LS, Freimark D, et al. Heart transplantation in patients with diabetic end-organ damage before transplantation. Thorac Cardiovasc Surg 1996 44: 282.
15. Lang CC, Beniaminovitz A, Edwards N, Mancini DM. Morbidity and mortality in diabetic patients following cardiac transplantation. J Heart Lung Transplant 2003 22: 244.
16. Czerny M, Sahin V, Fasching P, et al. The impact of diabetes mellitus at the time of heart transplantation on long-term survival. Diabetologia 2002 45: 1498.
17. Klingenberg R, Gleissner C, Koch A, et al. Impact of pre-operative diabetes mellitus upon early and late survival after heart transplantation: a possible era effect. J Heart Lung Transplant 2005 24: 1239.
18. Kapadia SR, Nissen SE, Ziada KM. Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study. J Am Coll Cardiol 2001 38: 206.
19. Valantine H, Rickenbacker P, Kemna M. Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease: a prospective study. Circulation 2001 103: 2144.
20. Marelli D, Laks H, Patel B, et al. Heart transplantation in patients with diabetes mellitus in the current era. J Heart Lung Transplant 2003 22: 1091.
21. Yacoub M, Alvizatos P, Khagani A, Mitchell A. The use of cyclocporine, azathioprine and antithymocyte globuline with or without low dose steroids for immunosuppression of cardiac transplant patients. Tranplant Proc 1985 17: 221.
22. Oaks TE, Wannenberg T, Close SA, Tuttle LE, Kon ND. Steroid-free maintenance immunosuppression after heart transplantation. Ann Thorac Surg 2001 72: 102.
23. Felkel TO, Smith AL, Reichenspurner HC, et al. Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy. J Heart Lung Transplant 2002 21: 530.